830 related articles for article (PubMed ID: 18413304)
61. Circulating angiogenic and antiangiogenic factors in women with eclampsia.
Vaisbuch E; Whitty JE; Hassan SS; Romero R; Kusanovic JP; Cotton DB; Sorokin Y; Karumanchi SA
Am J Obstet Gynecol; 2011 Feb; 204(2):152.e1-9. PubMed ID: 21062661
[TBL] [Abstract][Full Text] [Related]
62. In vitro and in vivo evidence for lack of endovascular remodeling by third trimester trophoblasts.
Kalkunte S; Lai Z; Tewari N; Chichester C; Romero R; Padbury J; Sharma S
Placenta; 2008 Oct; 29(10):871-8. PubMed ID: 18775564
[TBL] [Abstract][Full Text] [Related]
63. The perinatal implications of angiogenic factors.
Smith GC; Wear H
Curr Opin Obstet Gynecol; 2009 Apr; 21(2):111-6. PubMed ID: 19996864
[TBL] [Abstract][Full Text] [Related]
64. IFI16 mediates soluble Flt-1 and endoglin production by trophoblast cells.
Li N; Fu Y; Chen W; Hu GQ; Zhou M; Yu SX; Zhang XJ; Du CT; Yang YJ
J Hypertens; 2015 Aug; 33(8):1658-65. PubMed ID: 26002845
[TBL] [Abstract][Full Text] [Related]
65. [Study on p38 mitogen activated protein kinase in vascular endothelial cells dysfunction in preeclampsia].
Luo X; Liu DD; Qi HB; Yao ZW
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):36-40. PubMed ID: 21429433
[TBL] [Abstract][Full Text] [Related]
66. Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A.
Lamszus K; Ulbricht U; Matschke J; Brockmann MA; Fillbrandt R; Westphal M
Clin Cancer Res; 2003 Apr; 9(4):1399-405. PubMed ID: 12684411
[TBL] [Abstract][Full Text] [Related]
67. Hypoxia and preeclampsia: increased expression of urocortin 2 and urocortin 3.
Imperatore A; Rolfo A; Petraglia F; Challis JR; Caniggia I
Reprod Sci; 2010 Sep; 17(9):833-43. PubMed ID: 20616367
[TBL] [Abstract][Full Text] [Related]
68. An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study.
Romero R; Chaiworapongsa T; Erez O; Tarca AL; Gervasi MT; Kusanovic JP; Mittal P; Ogge G; Vaisbuch E; Mazaki-Tovi S; Dong Z; Kim SK; Yeo L; Hassan SS
J Matern Fetal Neonatal Med; 2010 Dec; 23(12):1384-99. PubMed ID: 20459337
[TBL] [Abstract][Full Text] [Related]
69. Markers of endothelial cell dysfunction are increased in human omental adipose tissue from women with pre-existing maternal obesity and gestational diabetes.
Lappas M
Metabolism; 2014 Jun; 63(6):860-73. PubMed ID: 24684825
[TBL] [Abstract][Full Text] [Related]
70. Placental expression of VEGF, PlGF and their receptors in a model of placental insufficiency-intrauterine growth restriction (PI-IUGR).
Regnault TR; Orbus RJ; de Vrijer B; Davidsen ML; Galan HL; Wilkening RB; Anthony RV
Placenta; 2002; 23(2-3):132-44. PubMed ID: 11945079
[TBL] [Abstract][Full Text] [Related]
71. Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells.
Ahmed A; Dunk C; Kniss D; Wilkes M
Lab Invest; 1997 Jun; 76(6):779-91. PubMed ID: 9194854
[TBL] [Abstract][Full Text] [Related]
72. Differential expression of vascular endothelial growth factor, placenta growth factor and their receptors in placentae from pregnancies complicated by placenta accreta.
Tseng JJ; Chou MM; Hsieh YT; Wen MC; Ho ES; Hsu SL
Placenta; 2006 Jan; 27(1):70-8. PubMed ID: 16310040
[TBL] [Abstract][Full Text] [Related]
73. [New insights into the pathogenesis of pre-eclampsia: the role of angiogenesis-inhibiting factors].
Verdonk K; Visser W; Steegers EA; Kappers M; Danser AH; van den Meiracker AH
Ned Tijdschr Geneeskd; 2011; 155():A2946. PubMed ID: 21486506
[TBL] [Abstract][Full Text] [Related]
74. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome.
Zhou Y; McMaster M; Woo K; Janatpour M; Perry J; Karpanen T; Alitalo K; Damsky C; Fisher SJ
Am J Pathol; 2002 Apr; 160(4):1405-23. PubMed ID: 11943725
[TBL] [Abstract][Full Text] [Related]
75. Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice.
Oggè G; Romero R; Kusanovic JP; Chaiworapongsa T; Dong Z; Mittal P; Vaisbuch E; Mazaki-Tovi S; Gonzalez JM; Yeo L; Hassan SS
J Matern Fetal Neonatal Med; 2010 Aug; 23(8):820-7. PubMed ID: 20158394
[TBL] [Abstract][Full Text] [Related]
76. Expression of angiogenesis-related genes in the cellular component of the blood of preeclamptic women.
Purwosunu Y; Sekizawa A; Yoshimura S; Farina A; Wibowo N; Nakamura M; Shimizu H; Okai T
Reprod Sci; 2009 Sep; 16(9):857-64. PubMed ID: 19474289
[TBL] [Abstract][Full Text] [Related]
77. YC-1 reduces placental sFlt-1 and soluble endoglin production and decreases endothelial dysfunction: A possible therapeutic for preeclampsia.
Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Tuohey L; Kaitu'u-Lino TJ
Mol Cell Endocrinol; 2015 Sep; 413():202-8. PubMed ID: 26159901
[TBL] [Abstract][Full Text] [Related]
78. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
[TBL] [Abstract][Full Text] [Related]
79. Nicotine restores endothelial dysfunction caused by excess sFlt1 and sEng in an in vitro model of preeclamptic vascular endothelium: a possible therapeutic role of nicotinic acetylcholine receptor (nAChR) agonists for preeclampsia.
Mimura K; Tomimatsu T; Sharentuya N; Tskitishvili E; Kinugasa-Taniguchi Y; Kanagawa T; Kimura T
Am J Obstet Gynecol; 2010 May; 202(5):464.e1-6. PubMed ID: 20223446
[TBL] [Abstract][Full Text] [Related]
80. Soluble and membranous vascular endothelial growth factor receptor-2 in pregnancies complicated by pre-eclampsia.
Tripathi R; Rath G; Ralhan R; Saxena S; Salhan S
Yonsei Med J; 2009 Oct; 50(5):656-66. PubMed ID: 19881969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
